AMRI Awarded API Contract
AMRI reported that its subsidiary, Albany Molecular Research, located in Holywell, Wales, United Kingdom, has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation by the Defense Science and Technology Laboratory, acting on behalf of the United Kingdom’s Secretary of State for Defense, the Department of National Defense of Canada, and Minister of Defense of the Kingdom of the Netherlands.
AMRI will initially work on the development and scale-up of the investigational drug, and the manufacture and supply for use during Phase I clinical trials. If the trials are successful, AMRI could become the commercial manufacturer of the product for distribution to the government partners of this contract, including the UK, the Netherlands, and Canada.
Source: AMRI
Columnists
Outsourcing
Commercializing Cell Therapies: Lonza’s Eytan Abraham on Challenges and Rewards
Better equipment and automated processes will be key. So, too, will the right way of approaching outsourcing relationships.
Tech Ops for Hire
As CMOs shed their old toll processing role, sponsors can expect the right questions, proactive communication, and a firm grasp of risk management and tech transfer from contract service providers.
Webcasts
- Enhancing Quality and Process Efficiency Using Continuous Manufacturing Technology for Drug Substance and Drug Product
- Safe and Cost-Effective Capsule Filling for Pre-Clinical and First-in-Man Studies
- Maximizing Roller Compaction Benefits with Proper Excipient Selection
- Developing a Comprehensive Tool Kit for Microbial Identification
Sponsored Links
